HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maureen T Kelly Selected Research

2- (4- (4- chlorobenzoyl)phenoxy)- 2- methylpropanoic acid

5/2009Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
2/2009Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.
1/2009Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
1/2009ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maureen T Kelly Research Topics

Disease

19Dyslipidemias (Dyslipidemia)
06/2014 - 12/2008
3Coronary Disease (Coronary Heart Disease)
06/2014 - 01/2008
2Type 2 Diabetes Mellitus (MODY)
02/2011 - 01/2010
2Hypertriglyceridemia
02/2011 - 01/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2014
1Chronic Renal Insufficiency
08/2013
1Cardiovascular Diseases (Cardiovascular Disease)
11/2012
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2010
1Hypercholesterolemia
01/2010
1Rhabdomyolysis
01/2010
1Myotoxicity
01/2010
1Headache (Headaches)
12/2008
1Nasopharyngitis
12/2008
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2008
1Back Pain (Backache)
12/2008

Drug/Important Bio-Agent (IBA)

20fenofibric acidFDA Link
06/2014 - 12/2008
17LipidsIBA
08/2013 - 01/2008
12Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2014 - 12/2008
10Rosuvastatin Calcium (Crestor)FDA Link
08/2013 - 01/2009
9Triglycerides (Triacylglycerol)IBA
06/2014 - 01/2009
9LDL CholesterolIBA
06/2014 - 01/2009
8HDL CholesterolIBA
06/2014 - 01/2009
8oxidized low density lipoproteinIBA
11/2012 - 01/2009
4Atorvastatin (Lipitor)FDA Link
06/2014 - 02/2009
42- (4- (4- chlorobenzoyl)phenoxy)- 2- methylpropanoic acidIBA
05/2009 - 01/2009
3Fibric Acids (Fibrates)IBA
06/2014 - 01/2010
3Simvastatin (Zocor)FDA LinkGeneric
02/2011 - 01/2009
2Choline (Choline Chloride)IBA
06/2014 - 01/2009
2Lipoproteins (Lipoprotein)IBA
11/2012 - 05/2011
2Biomarkers (Surrogate Marker)IBA
09/2011 - 05/2011
2Apolipoproteins B (ApoB)IBA
05/2011 - 02/2011
2LDL Lipoproteins (beta Lipoproteins)IBA
03/2011 - 02/2009
2HDL LipoproteinsIBA
03/2011 - 02/2009
2ApolipoproteinsIBA
02/2011 - 01/2010
1Fenofibrate (CiL)FDA LinkGeneric
06/2014
1C-Reactive ProteinIBA
09/2011
1Ezetimibe (Zetia)FDA Link
10/2010
1SaltsIBA
01/2009

Therapy/Procedure

17Therapeutics
06/2014 - 12/2008
1Aftercare (After-Treatment)
02/2011